ferric ferrocyanide has been researched along with Disease Models, Animal in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, M; Gao, W; He, R; Hou, W; Lu, J; Wu, J; Ye, C; Zhang, K; Zhang, W; Zhao, Y; Zheng, Y | 1 |
| Cui, Z; Li, J; Li, Z; Liang, Y; Liu, X; Tan, L; Wang, X; Wu, S; Yang, X; Yeung, KWK; Zheng, Y; Zhu, S | 1 |
| Jeon, J; Lee, MS; Sahu, A; Tae, G; Yang, HS | 1 |
| Cai, X; Chen, Z; Gao, W; Gu, W; Hu, B; Jin, C; Shi, J; Song, F; Tian, M; Tu, M; Wang, J; Yang, X; Zhang, H; Zhang, K; Zhang, Q; Zheng, Y; Zhu, Y | 1 |
| Cai, X; Gao, W; Hu, B; Li, Z; Xu, J; Zhao, J; Zheng, Y; Zou, D | 1 |
| Jiang, M; Jin, Y; Li, K; Li, X; Lin, J; Lu, X; Peng, C; Qin, J; Shen, Z; Xie, Q; Yang, X; Ye, K; Zhang, G | 1 |
| Johnstone, DM; Marotte, L; Purushothuman, S; Stone, J; Stowe, S | 1 |
| Cribbs, DH; Fisher, MJ; Grigoryan, MM; Liu, S; Paganini-Hill, A; Sumbria, RK; Vasilevko, V | 1 |
| Diao, XW; Fa, HB; Li, S; Yin, W; Zhang, D; Zhou, JT | 1 |
| Gijbels, MJ; Heeneman, S; Sluimer, JC | 1 |
| Cai, X; Chen, H; Gao, W; Hao, L; Sheng, D; Wang, R; Wang, Z; Xu, C; Yao, Y; Zhang, N; Zheng, Y | 1 |
| Burga, RA; Fernandes, R; Li, C; Sweeney, EE; Zhu, Y | 1 |
| Dai, Z; Jing, L; Li, X; Lin, L; Yang, Y; Yue, X | 1 |
| Azevedo-Pereira, RL; Cintra, WM; Gasparetto, EL; Godoy, MA; Mendez-Otero, R; Moraes, L; Rosado-de-Castro, PH; Santana, FC; Santiago, MF; Vasconcelos-dos-Santos, A | 1 |
| Arbab, AS; Brown, SL; Churchman, JL; Ding, G; Frank, JA; Iskander, AS; Jafari-Khouzani, K; Jiang, Q; Peck, DJ; Rad, AM; Soltanian-Zadeh, H | 1 |
| Gröhn, O; Jokivarsi, K; Jolkkonen, J; Laitinen, T | 1 |
| Cahill-Morasco, R; Goldfrank, LR; Hoffman, RS; Meggs, WJ; Shih, RD | 1 |
1 trial(s) available for ferric ferrocyanide and Disease Models, Animal
| Article | Year |
|---|---|
Effects of Prussian blue and N-acetylcysteine on thallium toxicity in mice.
Topics: Acetylcysteine; Acute Disease; Administration, Oral; Animals; Antidotes; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrocyanides; Injections, Intraperitoneal; Mice; Poisoning; Thallium | 1997 |
16 other study(ies) available for ferric ferrocyanide and Disease Models, Animal
| Article | Year |
|---|---|
Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis.
Topics: Aged; Animals; Bone Resorption; Cell Differentiation; Disease Models, Animal; Female; Ferrocyanides; Humans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis; Ovariectomy; RANK Ligand; Reactive Oxygen Species | 2022 |
Zinc-doped Prussian blue enhances photothermal clearance of Staphylococcus aureus and promotes tissue repair in infected wounds.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrocyanides; Humans; Infrared Rays; Laser Therapy; Male; Metal-Organic Frameworks; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Nanoparticles; NIH 3T3 Cells; Rats; Staphylococcal Infections; Treatment Outcome; Wound Healing; Wound Infection; Zinc | 2019 |
Nanozyme Impregnated Mesenchymal Stem Cells for Hepatic Ischemia-Reperfusion Injury Alleviation.
Topics: Animals; Disease Models, Animal; Ferrocyanides; Inflammation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Nanoparticles; Oxidation-Reduction; Oxidative Stress; Reperfusion Injury | 2021 |
Hollow Prussian Blue Nanozymes Drive Neuroprotection against Ischemic Stroke via Attenuating Oxidative Stress, Counteracting Inflammation, and Suppressing Cell Apoptosis.
Topics: Animals; Apoptosis; Brain; Brain Ischemia; Disease Models, Animal; Ferrocyanides; Humans; Inflammation; Ischemia; Nanocomposites; Neuroprotective Agents; Oxidative Stress; Rats; Reactive Oxygen Species; Stroke | 2019 |
Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Drug Carriers; Ferrocyanides; Free Radical Scavengers; Humans; Inflammatory Bowel Diseases; Mice; Nanostructures; Reactive Oxygen Species; Treatment Outcome | 2019 |
MRI of iron oxide nanoparticle-labeled ADSCs in a model of hindlimb ischemia.
Topics: Adipose Tissue; Animals; Cell Death; Cell Differentiation; Cell Survival; Disease Models, Animal; Ferric Compounds; Ferrocyanides; Flow Cytometry; Fluorescent Antibody Technique; Green Fluorescent Proteins; Hindlimb; Hydrodynamics; Immunohistochemistry; Ischemia; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Multipotent Stem Cells; Nanoparticles; Particle Size; Staining and Labeling; Stem Cell Transplantation; Stem Cells; Succimer | 2013 |
The response of cerebral cortex to haemorrhagic damage: experimental evidence from a penetrating injury model.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Benzothiazoles; Brain; Brain Injuries; Cell Death; Cerebral Cortex; Congo Red; Disease Models, Animal; Female; Ferrocyanides; Heme; Hemorrhage; Hippocampus; Humans; Immunohistochemistry; Male; Neocortex; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; tau Proteins; Temporal Lobe; Thiazoles; Wounds, Penetrating | 2013 |
Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Eosine Yellowish-(YS); Ferrocyanides; Hematoxylin; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Staining and Labeling | 2014 |
The detection of β-amyloid plaques in an Alzheimer's disease rat model with DDNP-SPIO.
Topics: 2-Naphthylamine; Acrylonitrile; Alzheimer Disease; Animals; Case-Control Studies; Coloring Agents; Congo Red; Contrast Media; Disease Models, Animal; Ferrocyanides; Hippocampus; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Amyloid; Rats; Spectrometry, Fluorescence | 2015 |
Detection of Intraplaque Hemorrhage in Mouse Atherosclerotic Lesions.
Topics: Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azo Compounds; Coloring Agents; Disease Models, Animal; Eosine Yellowish-(YS); Ferrocyanides; Genetic Predisposition to Disease; Hematoxylin; Hemorrhage; Mice; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Staining and Labeling | 2015 |
A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Carriers; Female; Ferrocyanides; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Humans; Liver; Nanoparticles; Optical Imaging; Photoacoustic Techniques; Rabbits; Theranostic Nanomedicine | 2016 |
Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Ferrocyanides; Hyperthermia, Induced; Infrared Rays; Laser Therapy; MAP Kinase Kinase Kinases; Mice; Nanoparticles; Neoplasm Proteins; Neurilemmoma; Neurofibromatosis 1; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Surface Plasmon Resonance | 2016 |
Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.
Topics: Adenocarcinoma; Animals; Contrast Media; Disease Models, Animal; Drug Carriers; Ferrocyanides; HeLa Cells; Heterografts; Humans; Hyperthermia, Induced; Lasers; Magnetic Fields; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Quantum Dots; Theranostic Nanomedicine | 2017 |
Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Proliferation; Dextrans; Disease Models, Animal; Ferrocyanides; Fibroblast Growth Factor 2; Huntington Disease; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nanoparticles; Neostriatum; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Staining and Labeling | 2012 |
Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study.
Topics: Animals; Brain; Brain Neoplasms; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Survival; Coloring Agents; Contrast Media; Dextrans; Disease Models, Animal; Feasibility Studies; Ferrocyanides; Ferrosoferric Oxide; Flow Cytometry; Gliosarcoma; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iron; Leukocytes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Monocytes; Oxides; Protamines; Rats; Rats, Inbred F344; Spleen | 2007 |
Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions.
Topics: Animals; Brain Edema; Cerebral Arteries; Cerebral Cortex; Disease Models, Animal; Ferrocyanides; Fluorescent Dyes; Hemosiderin; Intracranial Hemorrhages; Intracranial Thrombosis; Iron; Magnetic Resonance Imaging; Male; Movement Disorders; Rats; Rats, Wistar; Recovery of Function; Rose Bengal; Sensation Disorders; Stroke; Time Factors; Wound Healing | 2007 |